Skip to main content
Erschienen in: Breast Cancer 1/2018

23.06.2017 | Original Article

Objective assessment of reconstructed breast hardness using a durometer

verfasst von: Hiroki Mori, Noriko Uemura, Haruka Koga, Mutsumi Okazaki

Erschienen in: Breast Cancer | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Whether a durometer was suitable for objectively measuring reconstructed breast hardness was evaluated.

Methods

Subjects were 81 women who underwent expander-implant reconstructions following breast cancer ablation. Capsular contracture was evaluated with Baker grading. Capsular thickness was measured with T1-weighted MRI at the upper areola area. The durometer was placed on the upper areola. Multiple logistic regression analysis was performed to compare variables.

Results

On Baker grading, 17 breasts were Baker grade I, 52 breasts were Baker grade II, 11 breasts were Baker grade III, and 1 breast was Baker grade IV. Mean capsular thickness on MRI was 1.1 (SD 0.4) mm with Baker grade I, 1.2 (SD 0.3) mm with Baker grade II, 1.4 (SD 0.4) mm with Baker grade III, and 1.9 mm with Baker grade IV. Mean durometer value was 0 with Baker grade I, 0.2 (SD 0.5) with Baker grade II, 2.0 (SD 1.7), with Baker grade III, and 8 with Baker grade IV. Baker grade IV was excluded from analysis because there was only one case. When Baker grade III was defined as positive for hardness, multiple logistic regression analysis showed that durometer value was associated with Baker grade III (p = 0.0005), but capsular thickness was not. On receiver operating characteristic curve analysis of the durometer value for Baker grade III, the optimal cutoff value was 0.5 (sensitivity 0.92, 1-specificity 0.17, area under the curve 0.92).

Conclusions

The durometer offers an objective index of hardness that might replace the subjective Baker grading. Further studies are needed to confirm the utility of this index.
Literatur
1.
Zurück zum Zitat Wong CH, Samuel M, Tan BK, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006;118:1224–36.CrossRefPubMed Wong CH, Samuel M, Tan BK, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006;118:1224–36.CrossRefPubMed
2.
Zurück zum Zitat Berry MG, Cucchiara V, Davies DM. Breast augmentation: Part II–Adverse capsular contracture. J Plast Reconstr Aesthet Surg. 2010;63:2098–107.CrossRefPubMed Berry MG, Cucchiara V, Davies DM. Breast augmentation: Part II–Adverse capsular contracture. J Plast Reconstr Aesthet Surg. 2010;63:2098–107.CrossRefPubMed
3.
Zurück zum Zitat Baker JL. Augmentation mammaplasty. In: Grabb WC, editor. Plastic surgery. 3rd ed. Boston: Little, Brown; 1979. p. 719. Baker JL. Augmentation mammaplasty. In: Grabb WC, editor. Plastic surgery. 3rd ed. Boston: Little, Brown; 1979. p. 719.
4.
Zurück zum Zitat Zahavi A, Sklair ML, Ad-El DD. Capsular contracture of the breast: working towards a better classification using clinical and radiologic assessment. Ann Plast Surg. 2006;57:248–51.CrossRefPubMed Zahavi A, Sklair ML, Ad-El DD. Capsular contracture of the breast: working towards a better classification using clinical and radiologic assessment. Ann Plast Surg. 2006;57:248–51.CrossRefPubMed
5.
Zurück zum Zitat Fagrell D, Berggren A, Tarpila E. Capsular contracture around saline-filled fine textured and smooth mammary implants: a prospective 7.5-year follow-up. Plast Reconstr Surg. 2001;108:2108–12.CrossRefPubMed Fagrell D, Berggren A, Tarpila E. Capsular contracture around saline-filled fine textured and smooth mammary implants: a prospective 7.5-year follow-up. Plast Reconstr Surg. 2001;108:2108–12.CrossRefPubMed
6.
Zurück zum Zitat Akita S, Akino K, Yakabe A, et al. Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg. 2007;18:1164–9.CrossRefPubMed Akita S, Akino K, Yakabe A, et al. Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg. 2007;18:1164–9.CrossRefPubMed
7.
Zurück zum Zitat Greenwald D, Moloye O, Ondrovic L, et al. Mechanical and sensory testing of overfilled breast implants. Aesthet Surg J. 2006;26:29–34.CrossRefPubMed Greenwald D, Moloye O, Ondrovic L, et al. Mechanical and sensory testing of overfilled breast implants. Aesthet Surg J. 2006;26:29–34.CrossRefPubMed
8.
Zurück zum Zitat Roberts KL. Reliability and validity of an instrument to measure tissue hardness in breasts. Aust J Adv Nurs. 1998;16:19–23.PubMed Roberts KL. Reliability and validity of an instrument to measure tissue hardness in breasts. Aust J Adv Nurs. 1998;16:19–23.PubMed
10.
Zurück zum Zitat Hakelius L, Ohlsen L. Tendency to capsular contracture around smooth and textured gel-filled silicone mammary implants: a 5-year follow-up. Plast Reconstr Surg. 1997;100:1566–9.CrossRefPubMed Hakelius L, Ohlsen L. Tendency to capsular contracture around smooth and textured gel-filled silicone mammary implants: a 5-year follow-up. Plast Reconstr Surg. 1997;100:1566–9.CrossRefPubMed
11.
Zurück zum Zitat Klinger M, Caviggioli F, Klinger FM, et al. Autologous fat graft in scar treatment. J Craniofac Surg. 2013;24:1610–5.CrossRefPubMed Klinger M, Caviggioli F, Klinger FM, et al. Autologous fat graft in scar treatment. J Craniofac Surg. 2013;24:1610–5.CrossRefPubMed
12.
Zurück zum Zitat Moon KW, Song R, Kim JH, et al. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis. Rheumatol Int. 2012;32:2465–70.CrossRefPubMed Moon KW, Song R, Kim JH, et al. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis. Rheumatol Int. 2012;32:2465–70.CrossRefPubMed
13.
Zurück zum Zitat Choh CT, Wall ML, Brown MD, et al. Use of durometry in assessment of venous disease. Phlebology. 2010;25:94–9.CrossRefPubMed Choh CT, Wall ML, Brown MD, et al. Use of durometry in assessment of venous disease. Phlebology. 2010;25:94–9.CrossRefPubMed
14.
Zurück zum Zitat Niitsu M, Michizaki A, Endo A, et al. Muscle hardness measurement by using ultrasound elastography: a feasibility study. Acta Radiol. 2011;52:99–105.CrossRefPubMed Niitsu M, Michizaki A, Endo A, et al. Muscle hardness measurement by using ultrasound elastography: a feasibility study. Acta Radiol. 2011;52:99–105.CrossRefPubMed
15.
Zurück zum Zitat Rennekampff HO, Exner K, Lemperle G, Nemsmann B. Reduction of capsular formation around silicone breast implants by d-penicillamine in rats. Scand J Plast Reconstr Surg Hand Surg. 1992;26:253–5.CrossRefPubMed Rennekampff HO, Exner K, Lemperle G, Nemsmann B. Reduction of capsular formation around silicone breast implants by d-penicillamine in rats. Scand J Plast Reconstr Surg Hand Surg. 1992;26:253–5.CrossRefPubMed
16.
Zurück zum Zitat Cordeiro PG, Albornoz CR, McCormick B, et al. The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg. 2014;134:588–95.CrossRefPubMed Cordeiro PG, Albornoz CR, McCormick B, et al. The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg. 2014;134:588–95.CrossRefPubMed
17.
Zurück zum Zitat Zeplin PH, Corduff N. Influence of patient age on capsular contracture after aesthetic breast augmentation. Plast Surg (Oakv). 2015;23:67–9. Zeplin PH, Corduff N. Influence of patient age on capsular contracture after aesthetic breast augmentation. Plast Surg (Oakv). 2015;23:67–9.
18.
Zurück zum Zitat McGuire P, Reisman NR, Murphy DK. Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg. 2017;139:1–9.CrossRefPubMed McGuire P, Reisman NR, Murphy DK. Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg. 2017;139:1–9.CrossRefPubMed
19.
Zurück zum Zitat Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK. Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J. 2015;35:145–55.CrossRefPubMedPubMedCentral Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK. Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J. 2015;35:145–55.CrossRefPubMedPubMedCentral
Metadaten
Titel
Objective assessment of reconstructed breast hardness using a durometer
verfasst von
Hiroki Mori
Noriko Uemura
Haruka Koga
Mutsumi Okazaki
Publikationsdatum
23.06.2017
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 1/2018
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0791-y

Weitere Artikel der Ausgabe 1/2018

Breast Cancer 1/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.